SITAXA D 10+100 TAB

About

SITAXA D 10+100 TAB is a combination medication specifically designed for the management of type 2 diabetes mellitus. It contains two active ingredients: Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor. Sitagliptin works by increasing the levels of incretin hormones, which stimulate insulin release and decrease glucagon secretion, thereby lowering blood glucose. Dapagliflozin acts by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine and a reduction in blood sugar levels. This dual mechanism provides a comprehensive approach to glycemic control, helping to improve blood sugar levels, reduce HbA1c, and potentially offer cardiovascular and renal benefits in patients with type 2 diabetes, especially when diet and exercise alone are insufficient.

Uses

• Management of type 2 diabetes mellitus
• Improvement of glycemic control
• Reduction of HbA1c levels
• Adjunct to diet and exercise

Directions For Use

Take one tablet orally once daily in the morning, with or without food, as directed by your healthcare provider. Swallow the tablet whole.

Benefits

• Effective dual-action blood glucose lowering
• Reduces HbA1c significantly
• May offer cardiovascular and renal benefits
• Promotes glucose excretion via urine
• Stimulates insulin release naturally
• Convenient once-daily dosing

Side Effects

• Urinary tract infections (UTIs)
• Genital yeast infections
• Nausea
• Diarrhea
• Headache
• Dizziness
• Increased urination
• Hypoglycemia (when used with insulin/sulfonylurea)
• Back pain
• Nasopharyngitis
• Ketoacidosis (rare)
• Dehydration

Safety Measures

• Alcohol - Alcohol can affect blood sugar levels and increase the risk of hypoglycemia or ketoacidosis. Limit or avoid alcohol consumption.
• Pregnancy - Not recommended during pregnancy due to potential risks to the fetus. Discuss with your doctor if pregnant or planning pregnancy.
• Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and potentially harm the infant.
• Liver - Use with caution in patients with moderate to severe liver impairment. Dose adjustment may be necessary.
• Kidney - Not recommended for patients with severe renal impairment or end-stage renal disease. Renal function should be assessed before and during treatment.
• Lung - Generally safe for patients with lung conditions. No specific contraindications related to respiratory function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.